DEAE-Dextran: Clinical Trials

1 trial of DEAE-Dextran, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Not yet recruiting 1

Follow DEAE-Dextran: new trials by email Literature Review of DEAE-Dextran trials Research Report on DEAE-Dextran

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Adaptive Radiotherapy for Hepatocellular Carcinoma
Best Supportive Care (BSC), Personalized ultrafractionated stereotactic adaptive radiation therapy (PULSAR) - Hepatocellular Carcinoma (HCC)
Phase 3Not yet recruitingUniversity Health Network, Toronto602026-12-012026-10-26

Conditions studied

Carcinoma, Hepatocellular (1)

Sponsors

University Health Network, Toronto (1)

Countries

Canada (1)